Implications of Pharmacogenomics to the Management of IBS-Reference-Cited by-同舟云学术

Implications of Pharmacogenomics to the Management of IBS

Published:2019-03 Issue:4 Volume:17 Page:584-594
ISSN:1542-3565
Container-title:Clinical Gastroenterology and Hepatology
language:en
Short-container-title:Clinical Gastroenterology and Hepatology

Author:

Camilleri Michael^ORCID

Funder

National Institutes of Health

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference44 articles.

1. Pharmacogenomics in the clinic;Relling;Nature,2015

2. Pharmacogenomics: translating functional genomics into rational therapeutics;Evans;Science,1999

3. Pharmacogenetic variation at CYP2C9, CYP2C19, and CYP2D6 at global and microgeographic scales;Sistonen;Pharmacogenet Genomics,2009

4. Pharmacogenetic polymorphism as an independent risk factor for frequent hospitalizations in older adults with polypharmacy: a pilot study;Finkelstein;Pharmgenomics Pers Med,2016

5. Systematic review: cardiovascular safety profile of 5-HT(4) agonists developed for gastrointestinal disorders;Tack;Aliment Pharmacol Ther,2012

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacogenetics in IBS: update and impact of GWAS studies in drug targets and metabolism;Expert Opinion on Drug Metabolism & Toxicology;2024-05-03

2. Central Neuromodulators in Irritable Bowel Syndrome: Why, How, and When;American Journal of Gastroenterology;2024-04-09

3. Most patients with disorders of gut‐brain interaction receive pharmacotherapy with major or moderate drug‐gene interactions;Neurogastroenterology & Motility;2023-12-10

4. Potential Value of Biomarker-Based Approaches for Evaluation and Management of Costly Functional Gastrointestinal Diseases;Clinical Gastroenterology and Hepatology;2023-09

5. Study on the Mechanism of Action of ShenlingBaizhu Powder on Diarrhea-Predominant Irritable Bowel Syndrome Based on Metabolomics;Traditional Chinese Medicine;2023